Ameritas Investment Partners, Inc. - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 267 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.14 and the average weighting 0.4%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$99,228
-0.1%
1,656
+20.3%
0.00%0.0%
Q2 2023$99,282
+10.7%
1,377
+13.0%
0.00%0.0%
Q1 2023$89,670
+3.5%
1,2190.0%0.00%
+33.3%
Q4 2022$86,671
-16.7%
1,2190.0%0.00%
-40.0%
Q3 2022$104,000
-3.7%
1,2190.0%0.01%0.0%
Q2 2022$108,000
-21.2%
1,2190.0%0.01%0.0%
Q1 2022$137,000
-27.1%
1,2190.0%0.01%
-16.7%
Q4 2021$188,000
+10.6%
1,2190.0%0.01%0.0%
Q3 2021$170,000
-77.6%
1,219
-78.9%
0.01%
-77.8%
Q2 2021$759,000
-13.9%
5,7880.0%0.03%
-20.6%
Q1 2021$882,000
+55.0%
5,788
+1.2%
0.03%
+30.8%
Q4 2020$569,000
+0.5%
5,718
-3.7%
0.03%0.0%
Q3 2020$566,000
-14.8%
5,9370.0%0.03%
-18.8%
Q2 2020$664,000
+48.9%
5,937
-3.2%
0.03%
+28.0%
Q1 2020$446,000
-33.5%
6,134
-4.7%
0.02%
-16.7%
Q4 2019$671,000
-2.5%
6,434
-7.0%
0.03%
-3.2%
Q3 2019$688,000
-17.7%
6,915
-5.6%
0.03%
-18.4%
Q2 2019$836,000
-13.9%
7,322
-5.2%
0.04%
-15.6%
Q1 2019$971,000
-10.8%
7,726
-3.7%
0.04%
-23.7%
Q4 2018$1,088,000
+127.1%
8,019
+359.8%
0.06%
+168.2%
Q3 2018$479,000
+32.7%
1,7440.0%0.02%
+29.4%
Q2 2018$361,000
+26.2%
1,744
+0.7%
0.02%
+21.4%
Q1 2018$286,000
+16.3%
1,732
-3.7%
0.01%
+27.3%
Q4 2017$246,000
+6.5%
1,7990.0%0.01%0.0%
Q3 2017$231,000
+6.0%
1,7990.0%0.01%0.0%
Q2 2017$218,000
+25.3%
1,799
+9.4%
0.01%
+22.2%
Q1 2017$174,0001,6450.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Knott David M Jr 115,000$7,6822.90%
VILLERE ST DENIS J & CO LLC 483,347$32,2872.52%
Monarch Partners Asset Management LLC 62,327$4,163,4441.23%
Chicago Capital, LLC 319,054$21,312,8201.18%
RICE HALL JAMES & ASSOCIATES, LLC 285,634$19,080,3511.09%
Stephens Investment Management Group LLC 454,416$30,713,9770.56%
Smith, Graham & Co., Investment Advisors, LP 65,372$4,366,8500.53%
WOODSTOCK CORP 55,014$3,674,9350.49%
Court Place Advisors, LLC 15,533$1,037,6050.38%
ISTHMUS PARTNERS, LLC 19,830$1,324,6440.20%
View complete list of LIGAND PHARMACEUTICALS INC shareholders